Vimarsana
Biggest News Aggregation in the World

Lars Zender News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lars Zender. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lars Zender Today - Breaking & Trending Today

EQS-News: HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor - Vimarsana News

EQS-News: HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor

Published: November 23, 2022

EQS-News: HepaRegeniX GmbH / Key word(s): Personnel HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor 23.11.2022 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor  Tübingen (Germany), November 2...

Source: boersennews.de
Related Topics:
Baden WübergUnited KingdomBernard KatzMax DelbrKatja ArnoldLars ZenderShaun BrownAndreas BuschWolfgang AlbrechtBrigitte KellerAscenion GmbBayer PharmaJohann Wolfgang GoetheMc ServicesUniversity Hospital TubingenUniversity In FrankfurtGlobal Head Of Cardiovascular Research At HoechstBoehringer Ingelheim Venture FundGerman Cancer Research CenterDistribution ServicesShire PlcCyclerion Therapeutics IncMax Planck Institute Of Molecular GeneticsNovo HoldingsHeparegenix Gmbh
HepaRegeniX GmbH: HepaRegeniX Appoints Elias Papatheodorou as New Chairman of the Board of Directors - Vimarsana News

HepaRegeniX GmbH: HepaRegeniX Appoints Elias Papatheodorou as New Chairman of the Board of Directors

Published: March 30, 2022

TUBINGEN, GERMANY / ACCESSWIRE / March 30, 2022 / HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapy approaches for the treatment of acute and chronic liver diseases, announced

Source: finanznachrichten.de
Related Topics:
United StatesBaden WübergUnited KingdomElias PapatheodorouKatja ArnoldLars ZenderAndreas JungferShaun BrownGraham DixonWolfgang AlbrechtKostenloser WertpapierhandelAscenion GmbMc ServicesUniversity Hospital TubingenBoehringer Ingelheim Venture FundCornell UniversityIthaca CollegeNovo HoldingsHeparegenix GmbhManaging DirectorHeparegenix BoardMemo TherapeuticsCalliditas TherapeuticsMarina BiotechActivated Protein